HPV Detection Methods in Head and Neck Cancer

Aldo Venuti, Francesca Paolini

Research output: Contribution to journalArticle

Abstract

Human papillomavirus (HPV) infection is emerging as a major prognostic and predictive marker in head and neck squamous cell carcinoma (HNSCC). Researches are focused on the development of HPV detection assays specially designed for HNSCC. The HPV diagnosis in these tumours is relevant toprognosis even in an already-developed tumour, whereas in the cervix, where the HPV is the cause of almost all tumours, this information has less clinical relevance. The better outcome of HPV-associated HNSCC raises the question about the best methodologies to distinguish between HPV and non-HPV-associated SCC. However, no consensus has been reached on the optimal way to identify HPV-associated SCC and ancillary studies have utilised many different methodologies, including HPV polymerase chain reaction testing, HPV in situ hybridization analysis, immunohistochemical staining for p16, and newer techniques that are currently under investigation. The objective of this review is to explain and give examples of various techniques of HPV detection highlighting how they might be used clinically. Although currently insufficiently specific due to the possibility of HPV infection originating at other sites, methodologies utilising serum and plasma to measure HPV infection will also be described, mostly for their potential future development and use. Finally, DNA/RNA microarray platforms will be briefly summarized for their capacity to identify the profile of molecular changes in any particular HPV+/HPV- cancer. In this way, it is expected to be possible to correlate the appropriate transcriptome-based diagnosis to the patients' specific cancer risk.

Original languageEnglish
Pages (from-to)63-74
Number of pages12
JournalHead and Neck Pathology
Volume6
Issue numberSUPPL. 1
DOIs
Publication statusPublished - 2012

Fingerprint

Head and Neck Neoplasms
Papillomavirus Infections
Neoplasms
Human Development
Oligonucleotide Array Sequence Analysis
Transcriptome
Cervix Uteri
In Situ Hybridization
Consensus
RNA
Staining and Labeling

Keywords

  • DNA/RNA microarray
  • E7 monoclonal
  • HNSCC
  • HPV
  • IHC
  • ISH
  • Oropharynx cancer
  • PCR
  • Real-time PCR
  • RT-PCR
  • Serum antibodies

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Oncology
  • Otorhinolaryngology

Cite this

HPV Detection Methods in Head and Neck Cancer. / Venuti, Aldo; Paolini, Francesca.

In: Head and Neck Pathology, Vol. 6, No. SUPPL. 1, 2012, p. 63-74.

Research output: Contribution to journalArticle

Venuti, Aldo ; Paolini, Francesca. / HPV Detection Methods in Head and Neck Cancer. In: Head and Neck Pathology. 2012 ; Vol. 6, No. SUPPL. 1. pp. 63-74.
@article{e82aeb8728174a1cb5d8fb177a4b4f9d,
title = "HPV Detection Methods in Head and Neck Cancer",
abstract = "Human papillomavirus (HPV) infection is emerging as a major prognostic and predictive marker in head and neck squamous cell carcinoma (HNSCC). Researches are focused on the development of HPV detection assays specially designed for HNSCC. The HPV diagnosis in these tumours is relevant toprognosis even in an already-developed tumour, whereas in the cervix, where the HPV is the cause of almost all tumours, this information has less clinical relevance. The better outcome of HPV-associated HNSCC raises the question about the best methodologies to distinguish between HPV and non-HPV-associated SCC. However, no consensus has been reached on the optimal way to identify HPV-associated SCC and ancillary studies have utilised many different methodologies, including HPV polymerase chain reaction testing, HPV in situ hybridization analysis, immunohistochemical staining for p16, and newer techniques that are currently under investigation. The objective of this review is to explain and give examples of various techniques of HPV detection highlighting how they might be used clinically. Although currently insufficiently specific due to the possibility of HPV infection originating at other sites, methodologies utilising serum and plasma to measure HPV infection will also be described, mostly for their potential future development and use. Finally, DNA/RNA microarray platforms will be briefly summarized for their capacity to identify the profile of molecular changes in any particular HPV+/HPV- cancer. In this way, it is expected to be possible to correlate the appropriate transcriptome-based diagnosis to the patients' specific cancer risk.",
keywords = "DNA/RNA microarray, E7 monoclonal, HNSCC, HPV, IHC, ISH, Oropharynx cancer, PCR, Real-time PCR, RT-PCR, Serum antibodies",
author = "Aldo Venuti and Francesca Paolini",
year = "2012",
doi = "10.1007/s12105-012-0372-5",
language = "English",
volume = "6",
pages = "63--74",
journal = "Head and Neck Pathology",
issn = "1936-055X",
publisher = "Humana Press",
number = "SUPPL. 1",

}

TY - JOUR

T1 - HPV Detection Methods in Head and Neck Cancer

AU - Venuti, Aldo

AU - Paolini, Francesca

PY - 2012

Y1 - 2012

N2 - Human papillomavirus (HPV) infection is emerging as a major prognostic and predictive marker in head and neck squamous cell carcinoma (HNSCC). Researches are focused on the development of HPV detection assays specially designed for HNSCC. The HPV diagnosis in these tumours is relevant toprognosis even in an already-developed tumour, whereas in the cervix, where the HPV is the cause of almost all tumours, this information has less clinical relevance. The better outcome of HPV-associated HNSCC raises the question about the best methodologies to distinguish between HPV and non-HPV-associated SCC. However, no consensus has been reached on the optimal way to identify HPV-associated SCC and ancillary studies have utilised many different methodologies, including HPV polymerase chain reaction testing, HPV in situ hybridization analysis, immunohistochemical staining for p16, and newer techniques that are currently under investigation. The objective of this review is to explain and give examples of various techniques of HPV detection highlighting how they might be used clinically. Although currently insufficiently specific due to the possibility of HPV infection originating at other sites, methodologies utilising serum and plasma to measure HPV infection will also be described, mostly for their potential future development and use. Finally, DNA/RNA microarray platforms will be briefly summarized for their capacity to identify the profile of molecular changes in any particular HPV+/HPV- cancer. In this way, it is expected to be possible to correlate the appropriate transcriptome-based diagnosis to the patients' specific cancer risk.

AB - Human papillomavirus (HPV) infection is emerging as a major prognostic and predictive marker in head and neck squamous cell carcinoma (HNSCC). Researches are focused on the development of HPV detection assays specially designed for HNSCC. The HPV diagnosis in these tumours is relevant toprognosis even in an already-developed tumour, whereas in the cervix, where the HPV is the cause of almost all tumours, this information has less clinical relevance. The better outcome of HPV-associated HNSCC raises the question about the best methodologies to distinguish between HPV and non-HPV-associated SCC. However, no consensus has been reached on the optimal way to identify HPV-associated SCC and ancillary studies have utilised many different methodologies, including HPV polymerase chain reaction testing, HPV in situ hybridization analysis, immunohistochemical staining for p16, and newer techniques that are currently under investigation. The objective of this review is to explain and give examples of various techniques of HPV detection highlighting how they might be used clinically. Although currently insufficiently specific due to the possibility of HPV infection originating at other sites, methodologies utilising serum and plasma to measure HPV infection will also be described, mostly for their potential future development and use. Finally, DNA/RNA microarray platforms will be briefly summarized for their capacity to identify the profile of molecular changes in any particular HPV+/HPV- cancer. In this way, it is expected to be possible to correlate the appropriate transcriptome-based diagnosis to the patients' specific cancer risk.

KW - DNA/RNA microarray

KW - E7 monoclonal

KW - HNSCC

KW - HPV

KW - IHC

KW - ISH

KW - Oropharynx cancer

KW - PCR

KW - Real-time PCR

KW - RT-PCR

KW - Serum antibodies

UR - http://www.scopus.com/inward/record.url?scp=84864127158&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864127158&partnerID=8YFLogxK

U2 - 10.1007/s12105-012-0372-5

DO - 10.1007/s12105-012-0372-5

M3 - Article

C2 - 22782225

AN - SCOPUS:84864127158

VL - 6

SP - 63

EP - 74

JO - Head and Neck Pathology

JF - Head and Neck Pathology

SN - 1936-055X

IS - SUPPL. 1

ER -